Steve Shivers, PhD

PreludeDx

Laguna Hills, CA

Disclosures:

Employment: PreludeDx:VP Scientific Affairs:Employee
Compensation: :Role Topic Description-End Date:
Ownership: none
Leadership: none

Presentations

Sep 29

2986 - The PREDICT II Registry: A Prospective Study to Evaluate the Clinical Utility of a 7-Gene Predictive Biosignature on Treatment Decisions in Patients with Ductal Carcinoma In Situ

Hall F

03:00pm - 04:00pm PT